ATE324443T1 - Für adipozyten spezifische protein homologe - Google Patents

Für adipozyten spezifische protein homologe

Info

Publication number
ATE324443T1
ATE324443T1 AT98942266T AT98942266T ATE324443T1 AT E324443 T1 ATE324443 T1 AT E324443T1 AT 98942266 T AT98942266 T AT 98942266T AT 98942266 T AT98942266 T AT 98942266T AT E324443 T1 ATE324443 T1 AT E324443T1
Authority
AT
Austria
Prior art keywords
adipocytes
protein homologue
zsig39
polypeptides
specific
Prior art date
Application number
AT98942266T
Other languages
English (en)
Inventor
Paul O Sheppard
Jacqueline M Humes
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Application granted granted Critical
Publication of ATE324443T1 publication Critical patent/ATE324443T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT98942266T 1997-08-26 1998-08-26 Für adipozyten spezifische protein homologe ATE324443T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5698397P 1997-08-26 1997-08-26

Publications (1)

Publication Number Publication Date
ATE324443T1 true ATE324443T1 (de) 2006-05-15

Family

ID=22007782

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98942266T ATE324443T1 (de) 1997-08-26 1998-08-26 Für adipozyten spezifische protein homologe

Country Status (11)

Country Link
US (3) US6197930B1 (de)
EP (1) EP1009829B1 (de)
JP (1) JP3492999B2 (de)
KR (1) KR20010023325A (de)
CN (1) CN1272884A (de)
AT (1) ATE324443T1 (de)
AU (1) AU744254B2 (de)
CA (1) CA2301660A1 (de)
DE (1) DE69834334T2 (de)
NO (1) NO20000934L (de)
WO (1) WO1999010492A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6469158B1 (en) * 1992-05-14 2002-10-22 Ribozyme Pharmaceuticals, Incorporated Synthesis, deprotection, analysis and purification of RNA and ribozymes
US6642360B2 (en) * 1997-12-03 2003-11-04 Genentech, Inc. Secreted polypeptides that stimulate release of proteoglycans from cartilage
FR2767135B1 (fr) 1997-08-06 2002-07-12 Genset Sa Recepteur complexe lsr, activite, clonage, et application au diagnostic, a la prevention et/ou au traitement de d'obesite et des risques ou complications associes
US20020165143A1 (en) * 1997-12-03 2002-11-07 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP1056846A1 (de) * 1998-02-23 2000-12-06 Smithkline Beecham Plc Cerebellin-2-artige polypeptide und dafür kodierende dna
US6406884B1 (en) * 1999-06-18 2002-06-18 Millennium Pharmaceuticals, Inc. Secreted proteins and uses thereof
WO2000026363A1 (en) * 1998-11-04 2000-05-11 Genset GENOMIC AND COMPLETE cDNA SEQUENCES OF HUMAN ADIPOCYTE-SPECIFIC APM1 AND BIALLELIC MARKERS THEREOF
DE60041912D1 (de) 1999-02-10 2009-05-14 Serono Genetics Inst Sa Polymorphe marker des lsr-gens
AU772103B2 (en) 1999-02-19 2004-04-08 Zymogenetics Inc. Inhibitors for use in hemostasis and immune function
US6544946B1 (en) 1999-02-19 2003-04-08 Zymogenetics, Inc. Inhibitors for use in hemostasis and immune function
CA2374387A1 (en) * 1999-05-27 2000-12-07 Zymogenetics, Inc. Adipocyte complement related protein homolog zacrp7
US20050042719A1 (en) * 1999-05-27 2005-02-24 Zymogenetics, Inc. Adipocyte complement related protein homolog zacrp5
WO2001032868A1 (en) * 1999-11-04 2001-05-10 Genset Apm1 biallelic markers and uses thereof
US20020058617A1 (en) 2000-01-14 2002-05-16 Joachim Fruebis OBG3 globular head and uses thereof for decreasing body mass
US6989367B2 (en) 2000-01-14 2006-01-24 Genset S.A. OBG3 globular head and uses thereof
US7338787B2 (en) 2000-01-14 2008-03-04 Serono Genetics Institute S.A. Nucleic acids encoding OBG3 globular head and uses thereof
US6566332B2 (en) * 2000-01-14 2003-05-20 Genset S.A. OBG3 globular head and uses thereof for decreasing body mass
US6579852B2 (en) * 2000-01-14 2003-06-17 Genset S.A. OBG3 globular head and uses thereof for decreasing body mass
IL156864A0 (en) * 2001-01-16 2004-02-08 Genset Sa Polynucleotides and polypeptides and their use in metabolic disorders
EP1422241A1 (de) 2002-11-19 2004-05-26 Alexander Steinkasserer Verwendung der löslichen Formen des CD83 und dafür kodierender Nukleinsäuren zur Behandlung oder Vorbeugung von Krankheiten
US9102726B2 (en) * 2002-12-04 2015-08-11 Argos Therapeutics, Inc. Nucleic acid of recombination expression vector encoding soluble forms of CD83, host cells transformed/transfected therewith and pharmaceutical compositions containing same
US7169898B2 (en) 2002-12-04 2007-01-30 Alexander Steinkasserer Soluble CD83 proteins and use thereof for the treatment or prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cells
JP2011520959A (ja) * 2008-05-23 2011-07-21 アルゴス・セラピューティクス・インコーポレーテッド 新規可溶性ｃｄ８３ポリペプチド、配合物および使用法
CN102940875B (zh) * 2012-10-31 2015-09-30 中国人民解放军军事医学科学院微生物流行病研究所 Paa蛋白及由其制备的抗体与应用
BR112016000106B1 (pt) 2013-07-09 2023-11-21 Annexon, Inc. Anticorpos anti-c1q e usos dos mesmos, célula de hibridoma, composição farmacêutica e métodos de detecção de sinapses em uma amostra biológica referências cruzadas a pedidos relacionados
WO2016073685A1 (en) 2014-11-05 2016-05-12 Annexon, Inc. Humanized anti-complement factor c1q antibodies and uses thereof
EP3380518B1 (de) 2015-11-24 2026-03-25 Annexon, Inc. Anti-komplementfaktor-c1q-fab-fragmente und verwendungen davon
CN110195070B (zh) * 2019-05-31 2022-11-04 天津大学 大肠杆菌全局调控因子的突变基因crp及应用
US12486322B2 (en) 2021-12-13 2025-12-02 Annexon, Inc. Anti-complement factor C1q antibodies with single binding arms and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000037640A2 (en) 1998-12-22 2000-06-29 Genentech, Inc. Compositions and methods for the treatment of tumor
US5869330A (en) 1995-06-05 1999-02-09 Whitehead Institute For Biomedical Research DNA encoding a novel serum protein produced exclusively in adipocytes
NZ504548A (en) 1997-12-03 2003-06-30 Genentech Inc Polypeptides and nucleic acids encoding human chordin
AU2212299A (en) 1998-01-05 1999-07-26 Genentech Inc. Compositions and methods for the treatment of tumor
US6406884B1 (en) 1999-06-18 2002-06-18 Millennium Pharmaceuticals, Inc. Secreted proteins and uses thereof
CA2348157A1 (en) 1998-12-01 2000-06-08 Genentech, Inc. Methods and compositions for inhibiting neoplastic cell growth
CA2362427A1 (en) 1999-03-08 2000-09-14 Genentech, Inc. Compositions and methods for the treatment of immune related diseases

Also Published As

Publication number Publication date
NO20000934D0 (no) 2000-02-25
CA2301660A1 (en) 1999-03-04
DE69834334T2 (de) 2007-04-26
US20030171547A1 (en) 2003-09-11
NO20000934L (no) 2000-04-26
JP3492999B2 (ja) 2004-02-03
AU9036298A (en) 1999-03-16
AU744254B2 (en) 2002-02-21
EP1009829B1 (de) 2006-04-26
US6197930B1 (en) 2001-03-06
EP1009829A1 (de) 2000-06-21
US6482612B1 (en) 2002-11-19
CN1272884A (zh) 2000-11-08
JP2001513998A (ja) 2001-09-11
KR20010023325A (ko) 2001-03-26
DE69834334D1 (de) 2006-06-01
WO1999010492A1 (en) 1999-03-04

Similar Documents

Publication Publication Date Title
ATE324443T1 (de) Für adipozyten spezifische protein homologe
PL338139A1 (en) Protein homologues specific for adipocytes
ATE332368T1 (de) Selektion von proteinen mittels rns-protein fusionen
PT1140175E (pt) Anticorpos para o vegf-d truncado e suas utilizacoes
ATE172743T1 (de) Nachweis von kollagenabbau -i(in vivo)
ATE447613T1 (de) Verfahren zur identifikation von bindestellendomänen, die ihre epitopbindefähigkeit beibehalten
BG100771A (bg) Хематопоетичен протеин и материали и методи за неговото получаване
ATE135371T1 (de) Mit akuter pankreatitis assoziiertes protein, mittel zur diagnose von akuter pankreatitis
ES2149149T1 (es) Proteinas de fijacion de interleuquina-18, su preparacion y utilizacion.
PT686161E (pt) Novas sub-unidades humanas de alfa integrina 2
ATE533845T1 (de) Eukaryotische signalsequenzen zur polypeptid- expression und polypeptid-anzeigebibliotheken
ATE302274T1 (de) Methoden zur bestimmung von komponenten zur modulation des körpergewichts
DE69636437D1 (de) Ligand polypeptide für hypophyse g-protein gekoppeltes rezeptor-protein, deren herstellung und anwendung
ATE265542T1 (de) Verfahren zur hochauflösenden identifizierung von lösungsmittel-zugänglichen amidhydrogenen in polypeptiden
ATE372384T1 (de) Protein-tyrosin-phosphatase ptp-s31
DE69531958D1 (de) (1-3)-beta-d-glukon-bindungsprotein, antikörper der dieses protein erkennt undverwendung des proteins und antikörper
ATE323764T1 (de) Kappa/mu ähnliche proteintyrosinphosphatase, proteintyrosinphosphatase lambda
ATE366420T1 (de) Kit und verfahren zur bestimmung von protein esm- 1
ATE301712T1 (de) Z2-19a, ein menschliches homolog von dem protein 2-19
DE69831084D1 (de) Beta-defensine
DE69224631D1 (de) Bindendes protein fixierungstest.
WO2002059282A3 (en) Adipocyte complement related protein zacrp13
ATE147433T1 (de) Protein- und polypeptidvarianten mit erhöhter affinität für metallgebundene affinitätsmatrizen
WO2000073446A3 (en) Adipocyte complement related protein homolog zacrp6
PT723552E (pt) Oligopeptidos derivados de fragmentos de proteina reactiva c

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties